HER2 status in early breast cancer: Relevance of cell staining patterns, gene amplification and polysomy 17

This publication has 26 references indexed in Scilit:

• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
  Journal of Clinical Oncology, 2007
• Histopathologic Characteristics Predicting HER-2/neu Amplification in Breast Cancer
  The Breast Journal, 2005
• Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice
  Clinical Cancer Research, 2005
• Targeted Therapy in Breast Cancer
  Molecular & Cellular Proteomics, 2004
• Determination of HER-2 Status and Chromosome 17 Polysomy in Breast Carcinomas Comparing HercepTest and PathVysion FISH Assay
  American Journal of Clinical Pathology, 2004
• Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas without HER-2/neu Gene Amplification
  The Journal of Molecular Diagnostics, 2003
• Current Perspectives on HER2 Testing: A Review of National Testing Guidelines
  Laboratory Investigation, 2003
• Aneusomy 17 in Breast Cancer: Its Role in HER-2/neu Protein Expression and Implication for Clinical Assessment of HER-2/neu Status
  Laboratory Investigation, 2002
• Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
  Journal of Clinical Oncology, 2002
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene
  Science, 1987